COVID-19 has ushered in unprecedented times that none of us planned for, this includes the pharmaceutical industry. With travel restrictions prohibiting MSLs from visiting healthcare providers (HCPs) and access to HCPs being drastically limited, MSLs have had to make major changes to how they operate. I have spoken to MSLs who once thought the concept of “virtual MSLs” was years away...